✦ LIBER ✦

Pegylated Liposomal Doxorubicin plus Bortezomib in Relapsed or Refractory Multiple Myeloma: Efficacy and Safety in Patients with Renal Function Impairment

✍ Scribed by Bladé, Joan; Sonneveld, Pieter; San Miguel, Jesús F.; Sutherland, Heather J.; Hajek, Roman; Nagler, Arnon; Spencer, Andrew; Robak, Tadeusz; Cibeira, M. Teresa; Zhuang, Sen H.; Harousseau, Jean-Luc; Orlowski, Robert Z.

Book ID: 119936052
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 145 KB
Volume: 8
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2008.n.051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of lenalidomide

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

✍ Meletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

Bortezomib in recurrent and/or refractor

Bortezomib in recurrent and/or refractory multiple myeloma : Initial clinical experience in patients with impaired renal function

✍ Sundar Jagannath; Bart Barlogie; James R. Berenson; Seema Singhal; Raymond Alexa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients

✍ Gabriele Buda; Enrico Orciuolo; Sara Galimberti; Matteo Pelosini; Mario Petrini 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 66 KB

Bortezomib-dexamethasone combination in

Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function

✍ Andrea Nozza; Licia Siracusano; Santoro Armando 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 816 KB

A modified regimen of pegylated liposoma

A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma

✍ Gabriel N. Waterman; Ori Yellin; Regina A. Swift; Russell Mapes; Benjamin Eades; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB

Efficacy and Safety of Pegylated Liposom

Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome

✍ Joan Bladé; Pieter Sonneveld; Jesús F. San Miguel; Heather J. Sutherland; Roman 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 193 KB